Media coverage
2
Media coverage
Title Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma Media name/outlet News-Medical.Net Country/Territory Australia Date 14/02/23 URL ct.moreover.com/?a=50005744535&p=1gw&v=1&x=2u_Iz1uhH8v_Z1ut-kULkw Persons Mauricio Burotto Title Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma Media name/outlet Head Topics UK Country/Territory United Kingdom Date 14/02/23 URL ct.moreover.com/?a=50006957023&p=1gw&v=1&x=sXR9K0lQ0tI9aaUisJ1fsg Persons Mauricio Burotto